Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI)

Market Closed
10 Aug, 20:00
NASDAQ (CM) NASDAQ (CM)
$
6. 84
-0.3
-4.2017%
$
28.18M Market Cap
- P/E Ratio
- Div Yield
81,043 Volume
-0.1 Eps
$ 7.14
Previous Close
Investors:
Add Transaction
Day Range
6.6 7.3
Year Range
0.6 7.68
Want to track RMTI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rockwell Medical, Inc. (RMTI) Q3 2025 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q3 2025 Earnings Call Transcript

Rockwell Medical, Inc. ( RMTI ) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Company Participants Heather Hunter - Senior VP & COO Mark Strobeck - President, CEO & Director Jesse Neri - Senior VP & CFO Conference Call Participants Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Nicholas Sherwood - Maxim Group LLC, Research Division Anthony Vendetti - Maxim Group LLC, Research Division Presentation Operator Good morning, and welcome to Rockwell Medical's Third Quarter 2025 Results Conference Call and Webcast.

Seekingalpha | 9 months ago
Rockwell Medical (RMTI) Reports Q3 Loss, Lags Revenue Estimates

Rockwell Medical (RMTI) Reports Q3 Loss, Lags Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.05 per share a year ago.

Zacks | 9 months ago
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain

Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain

Rockwell Medical (RMTI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Zacks | 11 months ago
Rockwell Medical, Inc. (RMTI) Q2 2025 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q2 2025 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q2 2025 Earnings Conference Call August 14, 2025 8:00 AM ET Company Participants Heather H. Hunter - Senior VP & Chief Corporate Affairs Officer Jesse Neri - Senior VP & CFO Mark Strobeck - President, CEO & Director Conference Call Participants Jeremy Pearlman - Maxim Group LLC, Research Division Raghuram Selvaraju - H.C.

Seekingalpha | 0 year ago
Rockwell Medical (RMTI) Reports Q2 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) Reports Q2 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.05 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.01 per share a year ago.

Zacks | 0 year ago
Rockwell Medical, Inc. (RMTI) Q1 2025 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q1 2025 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Heather Hunter - SVP, Chief Corporate Affairs Officer Mark Strobeck - President & CEO Jesse Neri - CFO Conference Call Participants Ram Selvaraju - H.C. Wainwright Jeremy Pearlman - Maxim Group Operator Good morning, and welcome to Rockwell Medical's First Quarter 2025 Results Conference Call and Webcast.

Seekingalpha | 1 year ago
Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.02 per share a year ago.

Zacks | 1 year ago
Rockwell Medical, Inc. (RMTI) Q4 2024 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q4 2024 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET Company Participants Heather Hunter - Senior Vice President, Chief Corporate Affairs Officer Mark Strobeck - President & Chief Executive Officer Tim Chole - Chief Commercial Officer Jesse Neri - Chief Financial Officer Conference Call Participants Brandon Folkes - Rodman & Renshaw Ram Selvaraju - H.C. Wainwright Anthony Vendetti - Maxim Group Operator Good morning, and welcome to Rockwell Medical's Fourth Quarter and Full Year 2024 Results Conference Call and Webcast.

Seekingalpha | 1 year ago
Rockwell Medical (RMTI) Reports Q4 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) Reports Q4 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.02 per share a year ago.

Zacks | 1 year ago
Rockwell Medical's Dip Gives A Speculative Opportunity

Rockwell Medical's Dip Gives A Speculative Opportunity

Despite a 39% stock drop yesterday, Rockwell Medical's strong Q3 results and upcoming catalyst provide a solid buying opportunity for risk-takers. The stock's dip was due to reduced orders from its largest customer, but Rockwell is diversifying its customer base and entering the at-home dialysis market. Strategic initiatives, including new supply contracts and product line growth, are expected to mitigate revenue reductions and generate future growth.

Seekingalpha | 1 year ago
Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Heather Hunter - Senior Vice President & Chief Corporate Affairs Officer Mark Strobeck - President & Chief Executive Officer Jesse Neri - Senior Vice President of Finance Conference Call Participants Anthony Venditti - Maxim Group Operator Good morning and welcome to Rockwell Medical's Third Quarter 2024 Results Conference Call and Webcast. Please note, this event is being recorded.

Seekingalpha | 1 year ago
Rockwell Medical (RMTI) Surpasses Q3 Earnings and Revenue Estimates

Rockwell Medical (RMTI) Surpasses Q3 Earnings and Revenue Estimates

Rockwell Medical (RMTI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.07 per share a year ago.

Zacks | 1 year ago
Loading...
Load More